VistaGen Therapeutics
VTGN
VTGN
52 hedge funds and large institutions have $127M invested in VistaGen Therapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.48% more ownership
Funds ownership: 0.15% → 1.63% (+1.5%)
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$18.2M | |
| 2 | +$18.2M | |
| 3 | +$14.6M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$14.6M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$12.1M |
Top Sellers
| 1 | -$111K | |
| 2 | -$92K | |
| 3 | -$49.1K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$18K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$17K |